首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Lead optimization of isocytosine-derived xanthine oxidase inhibitors
Authors:Komal Bajaj  Sandeep Burudkar  Pranay Shah  Ashish Keche  Usha Ghosh  Prashant Tannu  Smriti Khanna  Ankita Srivastava  Nitin J Deshmukh  Amol Dixit  Yogesh Ahire  Anagha Damre  Kumar VS Nemmani  Asha Kulkarni-Almeida  Chandrika B-Rao  Rajiv Sharma  H Sivaramakrishnan
Institution:1. Department of Medicinal Chemistry, Piramal Healthcare Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India;2. Department of Drug Metabolism and Pharmacokinetics, Piramal Healthcare Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India;3. Discovery Informatics, Piramal Healthcare Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India;4. Department of High Throughput Screening and Biotechnology, Piramal Healthcare Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India;5. Department of Pharmacology, Piramal Healthcare Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India
Abstract:We report our attempts at improving the oral efficacy of low-nanomolar inhibitors of xanthine oxidase from isocytosine series through chemical modifications. Our lead compound had earlier shown good in vivo efficacy when administered intraperitoneally but not orally. Several modifications are reported here which achieved more than twofold improvement in exposure. A compound with significant improvement in oral efficacy was also obtained.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号